Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
CAL-120 | Taxol | Chemo | Chemotherapy | 0.0028769 | -0.1987 | 0.7463 | 0.3104 | 2.6390 | 0.0032354 | 0.97877 |
MDA-MB-468 | Etoposide | Topo II | Chemotherapy | 0.48754 | -0.5132 | 0.4291 | 0.1644 | 1.8475 | 0.69756 | 0.99577 |
MCF 10A | Topotecan | Topo I | Chemotherapy | 0.009871 | -0.2000 | 0.7653 | 0.1401 | 1.1478 | 0.01069 | 0.95965 |
MDA-MB-468 | Cisplatin | Chemo | Chemotherapy | 1.2638 | -0.2866 | 0.2872 | 0.0977 | 1.4057 | 1.9559 | 0.99503 |
MCF 10A | Taxol | Chemo | Chemotherapy | 0.0026843 | -0.1256 | 0.7023 | 0.2576 | 1.8234 | 0.003018 | 0.9967 |
MDA-MB-468 | Topotecan | Topo I | Chemotherapy | 0.015779 | -0.6577 | 1.0692 | 0.4464 | 2.1036 | 0.023029 | 0.99528 |
CAL-120 | Topotecan | Topo I | Chemotherapy | 0.007493 | -0.3364 | 0.9130 | 0.2556 | 1.1649 | 0.010414 | 0.97973 |
CAL-120 | Doxorubicin | Chemo | Chemotherapy | 0.009438 | -0.2475 | 0.6969 | 0.1356 | 1.3775 | 0.011488 | 0.99278 |
CAL-120 | Cisplatin | Chemo | Chemotherapy | 2.9328 | 0.1876 | 0.1824 | 0.0229 | 0.9231 | 4.0426 | 0.98856 |
PDX1328 | Topotecan | Topo I | Chemotherapy | 0.0059222 | -0.9128 | 1.0720 | 0.1509 | 0.4616 | 0.063175 | 0.94441 |
PDX1328 | Etoposide | Topo II | Chemotherapy | 0.80493 | -0.2805 | 0.3502 | 0.0172 | 1.4732 | 1.1571 | 0.98432 |
MDA-MB-468 | Doxorubicin | Chemo | Chemotherapy | 0.0054214 | -0.3392 | 0.9121 | 0.3191 | 2.4137 | 0.0067542 | 0.99424 |
MDA-MB-231 | Etoposide | Topo II | Chemotherapy | 0.7036 | 0.1203 | 0.2978 | 0.0095 | 1.5558 | 0.62323 | 0.99162 |
MDA-MB-231 | Taxol | Chemo | Chemotherapy | 0.0023185 | -0.1204 | 0.7021 | 0.2576 | 1.1720 | 0.0026636 | 0.96432 |
PDX1328 | Cisplatin | Chemo | Chemotherapy | 0.77968 | -0.4217 | 0.3154 | 0.0259 | 1.3251 | 1.2886 | 0.9879 |
PDX1328 | Doxorubicin | Chemo | Chemotherapy | 0.013267 | -0.7789 | 0.8023 | 0.1468 | 1.4934 | 0.021574 | 0.96338 |
MDA-MB-231 | Topotecan | Topo I | Chemotherapy | 0.029665 | -0.3241 | 0.7044 | 0.0793 | 0.6645 | 0.059258 | 0.94327 |
MCF 10A | Cisplatin | Chemo | Chemotherapy | 4.2937 | 0.3794 | 0.0952 | 0.0149 | 2.1287 | 2.4561 | 0.99519 |
MDA-MB-468 | Taxol | Chemo | Chemotherapy | 0.001354 | -0.5218 | 1.0076 | 0.5243 | 1.2795 | 0.0023644 | 0.95471 |
CAL-120 | Etoposide | Topo II | Chemotherapy | 0.47956 | -0.1663 | 0.3810 | 0.0949 | 1.2763 | 0.62593 | 0.99712 |
HCC1954 | Cisplatin | Chemo | Chemotherapy | 1.2467 | -0.0741 | 0.2747 | 0.0807 | 1.1281 | 1.7233 | 0.97383 |
MCF 10A | Doxorubicin | Chemo | Chemotherapy | 0.010766 | -0.3242 | 0.6549 | 0.1054 | 1.4229 | 0.012388 | 0.96407 |
PDX1328 | Taxol | Chemo | Chemotherapy | 0.002983 | -0.5332 | 0.9047 | 0.1888 | 3.1886 | 0.0036802 | 0.98401 |
HCC1954 | Doxorubicin | Chemo | Chemotherapy | 0.0071835 | -0.3378 | 0.7296 | 0.2544 | 1.4590 | 0.0086345 | 0.96869 |
MDA-MB-231 | Doxorubicin | Chemo | Chemotherapy | 0.0050428 | -0.4864 | 0.8179 | 0.2092 | 1.0560 | 0.0077676 | 0.95921 |